Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

BUY
$90.19 - $110.4 $182,364 - $223,228
2,022 New
2,022 $222,000
Q2 2023

Jul 11, 2023

SELL
$100.78 - $112.29 $4,736 - $5,277
-47 Reduced 1.64%
2,816 $307,000
Q1 2023

Apr 17, 2023

BUY
$96.86 - $114.01 $290 - $342
3 Added 0.1%
2,863 $289,000
Q4 2022

Jan 10, 2023

BUY
$95.06 - $111.52 $5,038 - $5,910
53 Added 1.89%
2,860 $0
Q3 2022

Oct 20, 2022

SELL
$96.76 - $112.03 $36,672 - $42,459
-379 Reduced 11.9%
2,807 $272,000
Q2 2022

Jul 11, 2022

SELL
$102.07 - $123.37 $219,042 - $264,752
-2,146 Reduced 40.25%
3,186 $346,000
Q1 2022

Apr 06, 2022

SELL
$114.02 - $139.04 $416,971 - $508,469
-3,657 Reduced 40.68%
5,332 $631,000
Q4 2021

Jan 07, 2022

BUY
$115.53 - $141.46 $17,791 - $21,784
154 Added 1.74%
8,989 $1.27 Million
Q3 2021

Oct 19, 2021

BUY
$116.66 - $129.06 $546,085 - $604,129
4,681 Added 112.69%
8,835 $1.04 Million
Q2 2021

Jul 16, 2021

BUY
$105.79 - $124.53 $165,138 - $194,391
1,561 Added 60.2%
4,154 $482,000
Q1 2021

Apr 29, 2021

BUY
$108.84 - $128.23 $43,753 - $51,548
402 Added 18.35%
2,593 $311,000
Q4 2020

Jan 14, 2021

SELL
$105.0 - $114.42 $55,545 - $60,528
-529 Reduced 19.45%
2,191 $240,000
Q3 2020

Oct 15, 2020

BUY
$91.64 - $111.29 $8,247 - $10,016
90 Added 3.42%
2,720 $296,000
Q2 2020

Jul 20, 2020

SELL
$76.57 - $98.0 $1.18 Million - $1.51 Million
-15,409 Reduced 85.42%
2,630 $240,000
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $12,564 - $18,372
200 Added 1.12%
18,039 $1.42 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $1.4 Million - $1.56 Million
17,839 New
17,839 $1.55 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Vigilare Wealth Management Portfolio

Follow Vigilare Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Vigilare Wealth Management with notifications on news.